Regeneron Pharmaceuticals (REGN) Cash & Current Investments (2009 - 2026)
Regeneron Pharmaceuticals' quarterly Cash & Current Investments came in at $8.8 billion in Q1 2026, up 4.84% year-on-year from $8.3 billion in Q1 2025, and up 1.73% quarter-over-quarter from $8.6 billion in Q4 2025.
Regeneron Pharmaceuticals has reported Cash & Current Investments for 18 years, with the latest figure at $8.8 billion in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments rose 4.84% year-over-year to $8.8 billion; the trailing twelve-month figure through Mar 2026 stood at $8.8 billion (up 4.84% YoY), and the FY2025 full-year result was $8.6 billion, down 4.52% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $8.8 billion, up from $8.6 billion in the prior quarter.
- The five-year high for Cash & Current Investments was $10.8 billion in Q4 2023, with the low at $7.0 billion in Q3 2022.
- Average Cash & Current Investments over 5 years is $8.8 billion, with a median of $8.8 billion recorded in 2026.
- Year-over-year, Cash & Current Investments soared 101.23% in 2022 and retreated 23.85% in 2025.
- Tracing REGN's Cash & Current Investments over 5 years: stood at $7.7 billion in 2022, then surged by 40.07% to $10.8 billion in 2023, then declined by 16.9% to $9.0 billion in 2024, then dropped by 4.52% to $8.6 billion in 2025, then rose by 1.73% to $8.8 billion in 2026.
- The last three Cash & Current Investments figures came in at $8.8 billion (Q1 2026), $8.6 billion (Q4 2025), and $8.4 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.13 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.01 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.75 Bn |
| Dec 31, 2025 | 8.61 Bn |
| Sep 30, 2025 | 8.44 Bn |
| Jun 30, 2025 | 7.47 Bn |
| Mar 31, 2025 | 8.35 Bn |
| Dec 31, 2024 | 9.01 Bn |
| Sep 30, 2024 | 9.80 Bn |
| Jun 30, 2024 | 9.81 Bn |
| Mar 31, 2024 | 10.52 Bn |
| Dec 31, 2023 | 10.84 Bn |
| Sep 30, 2023 | 9.91 Bn |
| Jun 30, 2023 | 8.93 Bn |
| Mar 31, 2023 | 8.96 Bn |
| Dec 31, 2022 | 7.74 Bn |
| Sep 30, 2022 | 7.02 Bn |
| Jun 30, 2022 | 7.57 Bn |
| Mar 31, 2022 | 7.05 Bn |
| Dec 31, 2021 | 5.69 Bn |
| Sep 30, 2021 | 5.79 Bn |
| Jun 30, 2021 | 3.91 Bn |
| Mar 31, 2021 | 3.50 Bn |
| Dec 31, 2020 | 3.59 Bn |
| Sep 30, 2020 | 3.03 Bn |
| Jun 30, 2020 | 3.14 Bn |
| Mar 31, 2020 | 4.00 Bn |
| Dec 31, 2019 | 3.21 Bn |
| Sep 30, 2019 | 2.88 Bn |
| Jun 30, 2019 | 2.67 Bn |
| Mar 31, 2019 | 3.23 Bn |
| Dec 31, 2018 | 2.81 Bn |
| Sep 30, 2018 | 2.19 Bn |
| Jun 30, 2018 | 1.68 Bn |
| Mar 31, 2018 | 1.62 Bn |
| Dec 31, 2017 | 1.41 Bn |
| Sep 30, 2017 | 1.38 Bn |
| Jun 30, 2017 | 1.27 Bn |
| Mar 31, 2017 | 1.31 Bn |
| Dec 31, 2016 | 1.04 Bn |
| Sep 30, 2016 | 1.41 Bn |
| Jun 30, 2016 | 696.51 Mn |
| Mar 31, 2016 | 849.18 Mn |
| Dec 31, 2015 | 1.05 Bn |
| Sep 30, 2015 | 895.64 Mn |
| Jun 30, 2015 | 604.25 Mn |
| Mar 31, 2015 | 742.16 Mn |
| Dec 31, 2014 | 900.48 Mn |
| Sep 30, 2014 | 1.04 Bn |
| Jun 30, 2014 | 816.91 Mn |
| Mar 31, 2014 | 648.13 Mn |
| Dec 31, 2013 | 693.98 Mn |
| Sep 30, 2013 | 445.32 Mn |
| Jun 30, 2013 | 537.51 Mn |
| Mar 31, 2013 | 307.71 Mn |
| Dec 31, 2012 | 308.10 Mn |
| Sep 30, 2012 | 262.55 Mn |
| Jun 30, 2012 | 301.02 Mn |
| Mar 31, 2012 | 432.30 Mn |
| Dec 31, 2011 | 526.94 Mn |
| Sep 30, 2011 | 245.50 Mn |
| Jun 30, 2011 | 309.68 Mn |
| Mar 31, 2011 | 226.44 Mn |
| Dec 31, 2010 | 249.37 Mn |
| Sep 30, 2010 | 479.05 Mn |
| Jun 30, 2010 | 306.34 Mn |
| Mar 31, 2010 | 117.31 Mn |
| Dec 31, 2009 | 341.33 Mn |
| Sep 30, 2009 | 250.32 Mn |
| Jun 30, 2009 | 271.47 Mn |